The independent source for health policy research, polling, and news.
12,641-12,660 of 112,920 results
Drugmakers across the world have signed a pact to manufacture and supply Merck's covid pill to more than 100 lower-income countries. Meanwhile, there's promising news about antiviral drug remdesivir's impact on the need to ventilate covid patients, and an old drug, fluvoxamine, may be useful.
New Orleans was a covid hot spot in March 2020, and the outbreak was attributed to Mardi Gras celebrations weeks earlier. Parades and large gatherings have been canceled or postponed in some form since then. This year, anyone participating will have to abide by strict regulations to reduce the spread of new cases, The American South reported.
As NBC News reports, Chicago-based company Center for Covid Control is already under investigation by multiple states and the Centers for Medicare and Medicaid Services. On Wednesday, Minnesota filed a lawsuit against that company as well as another firm, Doctors Clinical Laboratory.
From the imperfect tools we have to measure covid infections, there is good news that indicates the the omicron variant may have peaked in many communities across the nation. News outlets report on where that's the case.
Hospitals are where patients go in an emergency. But with critical staffing shortages at a time when admissions are surging, it's health care providers and facilities around the country that are in crisis and in need of solutions.
A final legal block to the federal requirement was just lifted in Texas, meaning most health workers in all states must now get vaccinated against covid. Yet, just weeks before the rule takes effect, it's still unclear how many are holding out — making it difficult for hospitals to prepare for potential staffing crunches.
Touching on a host of health care issues during his two-hour press conference, President Joe Biden defended shifting guidance from the Centers for Disease Control and Prevention saying, “the messages, to the extent they’ve been confusing — it’s because the scientists, they’re learning more." He also acknowledged his social spending plan would likely have to be carved up into pieces to pass Congress.
Today's early morning highlights from the major news organizations.
Editorial writers delve into these various public health issues.
Opinion writers examine these covid and vaccine topics.
Read recent commentaries about drug-cost issues.
Higher rates of obesity, high cholesterol and more were identified as long-term health impacts in survivors of 2017's Hurricane Maria. In other news, the Centers for Disease Control and Prevention added 22 international destinations to its "very high" covid risk list, including Israel and Australia.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
The proposal introduced by lawmakers is reportedly "nearly identical" to a law currently under review in Mississippi. Also: Maine's plans to fix its insurance exchange; mental health excuses for student absences in Kentucky; suspension of a Florida health official for trying to compel vaccines; and more.
News outlets cover moves by social media app Snapchat to limit kids' access to drug deals on its service, including making it more difficult to target users under 18 by changing its "Quick Add" system. In other news, airlines are stepping up safety and aircraft cleaning to combat covid.
Politico covers aggressive pushback from drugmakers and patient advocacy groups over the recent decision to strongly limit Medicare coverage of Alzheimer's drug Aduhelm. Meanwhile, Axios says six big health insurers dominate the fast-growing Medicare Advantage market.
In the face of global vaccine inequality, the World Health Organization says that there is "no evidence" that healthy children and adolescents need booster shots. Meanwhile, a German study says three Pfizer shots may protect people against the omicron variant of covid.
Meanwhile, Stat reports that low-cost biosimilar drug provision in the U.S. is being stymied by a "thicket" of patents. Other drug company news includes Bristol Myers Squibb plans, a $3 billion biotech fund aimed at disease "reversal," and big data's failure to combat covid.
Paxlovid appears to combat omicron covid, the drugmaker said, effectively working to prevent the virus from replicating. Canada just approved the drug for certain classes of covid patients, but reports from the Bay Area News Group highlight that finding the drug and its rivals remains hard in the U.S.
A study published Monday said that a genetic "locus" — a fixed position of a gene on a chromosome — near two olfactory genes is associated with covid-induced loss of smell and taste, NBC News reported. This risk factor increases the likelihood a person will lose their sense of smell or taste by 11%, researchers said.
© 2026 KFF